Geometric LFIA Strip Layout for Sensitive Biomarker Quantification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional lateral flow immunoassays (LFIAs) suffer from significant limitations, particularly in sensitivity and quantification, and multiplexing, automated sample processing, and AI-driven quantification to enable reliable, user-friendly, and multiplexing, automated sample processing, and AI-based detection, and AI-driven quantification to ensure reliable, user-friendly diagnostics for both clinical and at-home use.
Innovation Solution
A geometrically enhanced lateral flow immunoassay platform with a finger-prick blood collection cartridge and AI-based detection, incorporating non-linear patterns such as constriction zones, and sinusoidal, serpentine, meandering, spiral, and/or nozzle-diffuser designs to enhance mixing and flow control, and a two-step rotation mechanism for automated sample processing, enabling sensitive, reliable, and user-friendly point-of-care diagnostics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional LFIAs are used for qualitative detection, then the assay is simple and equipment-free, but sensitivity and quantification capability are limited
Solution Approach 1:
The patent transforms the traditional linear test line into geometric patterns (constriction zones, serpentine, spiral, meandering designs) that add spatial dimensionality to the assay. This geometric enhancement increases the surface area and interaction time between analytes and antibodies, thereby improving detection sensitivity without requiring complex external equipment
Solution Approach 2:
The patent modifies physical parameters of the test strip including the geometry of test lines, flow rates, and assay timing. By changing these parameters, the system achieves enhanced sensitivity and quantification capability while maintaining the simplicity of the LFIA format
2Adaptability or versatility
If conventional LFIAs are designed for single-analyte detection, then the assay is simple and focused, but multiplexing capability is limited
Solution Approach 1:
The patent divides the test strip into multiple distinct test lines, each designed to detect a specific analyte. This segmentation allows simultaneous detection of multiple biomarkers (multiplexing) while keeping each individual detection channel simple and focused
Solution Approach 2:
The patent creates a universal test strip platform that can detect multiple different analytes using the same basic LFIA architecture. The geometric enhancement design serves multiple functions: enhancing sensitivity for each analyte while also enabling multiplexed detection across several test lines
3Ease of operation
If manual sample processing steps are used, then the kit is simple to manufacture, but user error risk increases and ease of use decreases
Solution Approach 1:
The patent incorporates pre-filled buffer reservoirs and pre-configured test strips into the device. The buffer is prepared and stored in advance, and the test strip is pre-assembled with all necessary components, eliminating the need for users to perform complex mixing or preparation steps
Solution Approach 2:
The device is designed to perform sample processing automatically through its internal architecture. The capillary action and geometric design enable self-mixing and self-regulation of flow, reducing reliance on user skill and minimizing manual intervention requirements
4Measurement precision
If geometric modifications are made to enhance test line intensity, then sensitivity improves, but manufacturing precision requirements increase
Solution Approach 1:
The patent optimizes geometric parameters (constriction zone dimensions, serpentine patterns, spiral configurations) to achieve enhanced signal intensity. By carefully selecting and standardizing these parameters during manufacturing, the system maintains both high sensitivity and manufacturability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The platform achieves improved sensitivity, quantification, and ease of use, with a limit of detection as low as 0.55±0.04 ng/mL for hepatitis B antigens, and expanded dynamic range from 5-1000 to 1-1000 ng/mL, suitable for early disease diagnosis and home use by non-experts.
Implementation Method 1
a nitrocellulose membrane with test and control lines, and a wicking pad that drives capillary flow
Data Source
AI summary
Lateral flow immunoassay systems include test strips having unique geometries to enhance fluid dynamics, including but not limited to: (1) conjugate pads having sinusoidal, meandering, and nozzle-diffuser patterns; and (2) nitrocellulose membrane pads having constriction zones corresponding to the location of T-lines and/or C-lines. The systems can further include a cartridge with a two-step rotation mechanism for contamination-free sample delivery to the sample pad of a test strip, and an AI-based detection system for quantifying the concentration of a detected analyte based on colorimetric signal intensities. The system exhibits improved analyte sensitivity over prior systems, reduces traditional assay time, eliminates subjective interpretation of colorimetric signal intensities, and quantifies analyte concentration levels.